BioStrand
BioStrand is a biotech company revolutionizing antibody drug discovery and biotherapeutics through its patented LENSai Integrated Intelligence Technology powered by HYFTs. The company offers a cloud-hosted SaaS platform that integrates multi-omics data from diverse sources to provide comprehensive insights, accelerating drug discovery timelines by up to 300%. Their technology combines in silico, in vitro, and in vivo methods to optimize lead candidate identification, reduce costs, and improve clinical success. BioStrand operates globally as an independently operating subsidiary of ImmunoPrecise Antibodies Ltd, partnering with top pharmaceutical and technology companies to transform antibody discovery with AI-driven data integration and advanced analytics.
BioStrand
BioStrand is a biotech company revolutionizing antibody drug discovery and biotherapeutics through its patented LENSai Integrated Intelligence Technology powered by HYFTs. The company offers a cloud-hosted SaaS platform that integrates multi-omics data from diverse sources to provide comprehensive insights, accelerating drug discovery timelines by up to 300%. Their technology combines in silico, in vitro, and in vivo methods to optimize lead candidate identification, reduce costs, and improve clinical success. BioStrand operates globally as an independently operating subsidiary of ImmunoPrecise Antibodies Ltd, partnering with top pharmaceutical and technology companies to transform antibody discovery with AI-driven data integration and advanced analytics.